Long-Term Surveillance of Growth Hormone Therapy

被引:50
作者
Rosenfeld, Ron G. [1 ]
Cohen, Pinchas [2 ]
Robison, Leslie L. [3 ]
Bercu, Barry B. [4 ]
Clayton, Peter [5 ]
Hoffman, Andrew R. [6 ]
Radovick, Sally [7 ]
Saenger, Paul [8 ]
Savage, Martin O. [9 ]
Wit, Jan M. [10 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
[2] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[3] St Jude Childrens Hosp, Memphis, TN 38105 USA
[4] Univ S Florida, Coll Med, Tampa, FL 33612 USA
[5] Univ Manchester, Manchester M13 9PL, Lancs, England
[6] Stanford Univ, Stanford, CA 94305 USA
[7] Johns Hopkins Med Inst, Baltimore, MD 21287 USA
[8] Montefiore Med Ctr, Bronx, NY 10467 USA
[9] St Bartholomews & Royal London Sch Med & Dent, London E1 2AD, England
[10] Leiden Univ, Med Ctr, NL-2333 AA Leiden, Netherlands
关键词
CHILDHOOD-CANCER SURVIVOR; 2ND NEOPLASMS; RISK; CHILDREN; SAFETY; GH;
D O I
10.1210/jc.2011-2294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oregon Health & Science University (R.G.R.), Portland, Oregon 97239; University of California-Los Angeles (P.Co.), Los Angeles, California 90095; St. Jude Children's Research Hospital (L.L.R.), Memphis, Tennessee 38105; University of South Florida College of Medicine (B.B.B.), Tampa, Florida 33612; The University of Manchester (P.Cl.), Manchester M13 9PL, United Kingdom; Stanford University (A.R.H.), Stanford, California 94305; Johns Hopkins Medical Institutions (S.R.), Baltimore, Maryland 21287; Montefiore Medical Center (P.S.), Bronx, New York 10467; Saint Bartholomew's and the Royal London School of Medicine and Dentistry (M.O.S.), London E1 2AD, United Kingdom; and Leiden University Medical Center (J.M.W.), 2333 ZA Leiden, The Netherlands
引用
收藏
页码:68 / 72
页数:5
相关论文
共 14 条
  • [1] [Anonymous], 93 ANN M END SOC BOS
  • [2] Long-Term Safety of Recombinant Human Growth Hormone in Children
    Bell, J.
    Parker, K. L.
    Swinford, R. D.
    Hoffman, A. R.
    Maneatis, T.
    Lippe, B.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 167 - 177
  • [3] Role of the growth hormone-IGF-1 axis in cancer
    Chhabra, Yash
    Waters, Michael J.
    Brooks, Andrew J.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (01) : 71 - 84
  • [4] Does the GH-IGF axis play a role in cancer pathogenesis?
    Cohen, P
    Clemmons, DR
    Rosenfeld, RG
    [J]. GROWTH HORMONE & IGF RESEARCH, 2000, 10 (06) : 297 - 305
  • [5] Variable Degree of Growth Hormone (GH) and Insulin-Like Growth Factor (IGF) Sensitivity in Children with Idiopathic Short Stature Compared with GH-Deficient Patients: Evidence from an IGF-Based Dosing Study of Short Children
    Cohen, Pinchas
    Germak, John
    Rogol, Alan D.
    Weng, Wayne
    Kappelgaard, Anne-Marie
    Rosenfeld, Ron G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) : 2089 - 2098
  • [6] Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control
    Colditz, Graham A.
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (05) : 649 - 656
  • [7] Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor
    Ergun-Longmire, Berrin
    Mertens, Ann C.
    Mitby, Pauline
    Qin, Jing
    Heller, Glenn
    Shi, Weiji
    Yasui, Yutaka
    Robison, Leslie L.
    Sklar, Charles A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) : 3494 - 3498
  • [8] Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
    Guevara-Aguirre, Jaime
    Balasubramanian, Priya
    Guevara-Aguirre, Marco
    Wei, Min
    Madia, Federica
    Cheng, Chia-Wei
    Hwang, David
    Martin-Montalvo, Alejandro
    Saavedra, Jannette
    Ingles, Sue
    de Cabo, Rafael
    Cohen, Pinchas
    Longo, Valter D.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (70)
  • [9] Long-Term Safety of Growth Hormone Replacement after CNS Irradiation
    Mackenzie, S.
    Craven, T.
    Gattamaneni, H. R.
    Swindell, R.
    Shalet, S. M.
    Brabant, G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09) : 2756 - 2761
  • [10] Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
    Renehan, AG
    Zwahlen, M
    Minder, C
    O'Dwyer, ST
    Shalet, SM
    Egger, M
    [J]. LANCET, 2004, 363 (9418) : 1346 - 1353